Abstract: Suggested are polyurea microcapsules obtainable or obtained by reacting di- and/or polyisocyanates and guanidine carbonate in the presence of chemically modified biopolymer colloidal protection agents. The capsules can be loaded for example with fragrances and show high resistance against agglomeration in unstructured (viscosity 10-300 cps), anionic surfactant based liquid products.

Abstract: Suggested is a non-disposable multi-use article which is impregnated or coated with a care additive and is capable of transferring said care additive from its surface to human skin.

Abstract: A medicament packaging assembly for installation in a medicament delivery device is disclosed. The packaging assembly comprises a cartridge having a medicament chamber, a sealing element for sealing a distal end of the medicament chamber, a sealing element release member, a cannula and a removable cap member. The assembly is switchable from a starting configuration in which the release member is spaced from the sealing element to an activated configuration in which the release member cooperates with the sealing element to connect the medicament chamber to the cannula. The packaging assembly further comprises a first chamber defined in part by the cap member and arranged for receiving the cannula such that at least a distal end of the cannula is sealed in the first chamber when the cap member is in place, and a second chamber defined in part by the sealing element and arranged for receiving the release member.

Abstract: A medicament delivery device is disclosed, comprising a cartridge assembly that comprises a cartridge having a medicament chamber for containing a medicament, a sealing element for sealing a distal end of the medicament chamber and a coupling element attached to the cartridge. The device also includes a sealing element release member, a cannula for delivery of the medicament, and a removable cap. The device is switchable from a starting configuration in which the release member is spaced from the sealing element to an activated configuration in which the release member cooperates with the sealing element to connect the medicament chamber to the cannula. A proximal end of the release member is sealed in a release member chamber defined in part by, the sealing element and in part by the coupling element.

Abstract: A motor grader having ride control for dampening machine bounce using a DCM assembly rotatably coupled to and suspended from a frame of the motor grader is disclosed. Each lift cylinder for the DCM may have an associated ride control circuit with an accumulator, a ride control conduit fluidly connected to a carry end of the lift cylinder and having a flow restriction element, and a ride control accumulator valve fluidly connected to the accumulator and the ride control conduit and operable to either block or allow fluid communication between the carry end and the accumulator through the flow restriction element. Each rid control circuit may also include a head end valve fluidly connected to between the head end of the lift cylinder and a low pressure fluid reservoir and operable to block or allow fluid communication between the head end and the low pressure fluid reservoir.

Abstract: A glass substrate according to one or more embodiments is disclosed. The glass substrate includes an alkali-containing bulk, at least one first alkali-depleted region, and at least one second alkali-depleted region. The alkali-containing bulk has a first surface and a second surfaces with the first and second surfaces opposing one another. The at least one first alkali-depleted region extends into the alkali-containing bulk from the first surface. The at least one second alkali-depleted region extends into the alkali-containing bulk from the second surface. The first alkali-depleted region and the second alkali-depleted region are amorphous and have a substantially homogenous composition. The first alkali-depleted region in some embodiments is a first alkali-depleted surface layer that extends across the alkali-containing bulk. The first alkali-depleted region in some embodiments is plurality of first alkali-depleted regions that are spaced apart from one another.

Abstract: The present invention relates to compounds which are intermediates in the synthesis of bile acid derivatives with pharmacological activity. The invention relates to compounds of general formula (I): wherein: , R1, R2, R3, R4, R5, R6 and Y are as defined herein. The compounds are intermediates in the synthesis of synthetic bile acids which are useful in the treatment of conditions such as liver disease. In addition, the invention relates to a method of synthesizing these intermediates and a method of preparing obeticholic acid and obeticholic acid analogues from the compounds of the invention.

Abstract: Methods and systems are provided for an engine housing assembly. In one example, an engine housing assembly comprises an engine housing component, the housing component at least partially defining a first bore for receiving a first shaft and at least partially defining a second bore for receiving a second shaft; and a reinforcement member cast into the housing, the reinforcement member having a lower coefficient of thermal expansion than the housing component, wherein the reinforcement member at least partially surrounds the first and second bores. A method of manufacturing the engine housing assembly is also provided.

Abstract: A leading edge structure for providing an aerodynamic surface of an aircraft is disclosed having a skin structure, the skin structure providing an outer aerodynamic surface and an inner surface, both surfaces extending in a chordwise and spanwise direction of the structure, and a plurality of structural members, each structural member being connected to the inner surface of the skin structure and extending in the chordwise direction along the inner surface, wherein the structural members are integrally formed with the inner surface of the skin structure. The disclosure is also related to an aircraft wing, aircraft tailplane, wing box structure, wing or wing structure and an aircraft including the leading edge structure.

Abstract: A medicament delivery device (100; 300; 400) comprises a chassis (124), a drive element (166) for driving a stopper (22) to expel the medicament through a cannula (144). A carrier (126) is arranged for movement with respect to the chassis (124). Insertion means (130, 202) biases the carrier (126) in an insertion direction. A control part (132) is biased for rotation with respect to the carrier (126). A locking element (176) prevents rotation of the control part (132) in an initial state. The locking element (176) is coupled to the drive element (166) such that the control part (132) is released for rotation when the drive element (166) reaches an activation position during a delivery stroke. Rotation of the control part (132) through a predetermined angle causes decoupling of the insertion means (130, 202) from the carrier (126) to allow movement of the carrier (126) in a retraction direction after the end of the delivery stroke.

Abstract: A medicament packaging assembly for installation in a medicament delivery device is disclosed. The packaging assembly comprises a cartridge having a medicament chamber, a sealing element for sealing a distal end of the medicament chamber, a sealing element release member, a cannula and a removable cap member. The assembly is switchable from a starting configuration in which the release member is spaced from the sealing element to an activated configuration in which the release member cooperates with the sealing element to connect the medicament chamber to the cannula.

Abstract: A system and method for resource estimation of an additive manufacturing device is disclosed herein. The system includes at least one processor and one or more software modules. The processor executes the one or more software modules to determine a number of parts that can be manufactured per manufacturing run, estimate manufacturing time to manufacture a specified number of parts, and determine a total cost to manufacture the number of parts with the additive manufacturing device. The one or more software modules can compare the total cost to the cost of a current manufacturing method.

Abstract: A medicament delivery device comprising a cannula for delivery of medicament, a cartridge assembly comprising a cartridge having a medicament chamber and a collar adjacent a distal end opening of the chamber, a sealing element for sealing the distal end opening, and a coupling element for retaining the sealing element against a distal end of the cartridge. The device further comprises a hub assembly comprising a hub body and a sealing element release member. The device is switchable from a starting configuration in which the release member is spaced from the sealing element to an activated configuration in which the release member cooperates with the sealing element to connect the medicament chamber to the cannula. The coupling element comprises an annular clamping portion for applying a clamping force to the sealing element to seal the sealing element against the distal end of the cartridge, and a generally tubular engagement portion.

Abstract: A medicament delivery device is disclosed, comprising a cartridge assembly that comprises a cartridge having a medicament chamber for containing a medicament, a sealing element for sealing a distal end of the medicament chamber and a coupling element attached to the cartridge. The device also includes a sealing element release member, a cannula for delivery of the medicament, and a removable cap. The device is switchable from a starting configuration in which the release member is spaced from the sealing element to an activated configuration in which the release member cooperates with the sealing element to connect the medicament chamber to the cannula. A proximal end of the release member is sealed in a release member chamber defined in part by, the sealing element and in part by the coupling element.

Abstract: A cartridge (100) for packaging a medicament and being suitable for use with multiple different types of dosing device is described, together with dosing devices and adaptors for dosing devices. The cartridge includes a generally tubular body (102) having an interior cavity (104), a closure member (106) disposed at a distal end of the body and comprising a sealing element (128), a piston member (108) disposed in the cavity to contain the medicament between the piston member and the sealing element (128), a coupling element (114) disposed at the distal end of the body for coupling the cartridge to a dosing device (200) or to an adaptor for a dosing device, and a seal arrangement (126, 129) for receiving a sealing element release member (214) of the dosing device or adaptor.

Abstract: A method, system, and machine for controlling the output of an engine of a machine includes calculating the difference between a measured track slip based on track speed and ground speed and a calculated target track slip depending on track speed and chassis pitch, inputting the difference into a controller to determine a propulsion engine torque limit, and limiting the engine toque to the propulsion engine torque limit plus a steering system input torque.

Abstract: The present invention relates to compounds which are intermediates in the synthesis of bile acid derivatives with pharmacological activity. The invention relates to compounds of general formula (I): wherein: , R1, R2, R3, R4, R5, R6 and Y are as defined herein. The compounds are intermediates in the synthesis of synthetic bile acids which are useful in the treatment of conditions such as liver disease. In addition, the invention relates to a method of synthesizing these intermediates and a method of preparing obeticholic acid and obeticholic acid analogues from the compounds of the invention.

Abstract: A motor grader having ride control for dampening machine bounce using a DCM assembly rotatably coupled to and suspended from a frame of the motor grader is disclosed. Each lift cylinder for the DCM may have an associated ride control circuit with an accumulator, a ride control conduit fluidly connected to a carry end of the lift cylinder and having a flow restriction element, and a ride control accumulator valve fluidly connected to the accumulator and the ride control conduit and operable to either block or allow fluid communication between the carry end and the accumulator through the flow restriction element. Each rid control circuit may also include a head end valve fluidly connected to between the head end of the lift cylinder and a low pressure fluid reservoir and operable to block or allow fluid communication between the head end and the low pressure fluid reservoir.

Abstract: The present invention relates to compounds which are intermediates in the synthesis of bile acid derivatives with pharmacological activity. The invention relates to compounds of general formula (I): wherein: , R1, R2, R3, R4, R5, R6 and Y are as defined herein. The compounds are intermediates in the synthesis of synthetic bile acids which are useful in the treatment of conditions such as liver disease. In addition, the invention relates to a method of synthesizing these intermediates and a method of preparing obeticholic acid and obeticholic acid analogues from the compounds of the invention.

Abstract: The present disclosure relates generally to custom medical devices and additive manufacturing (3D printing) processes for producing the same. Using certain materials and novel fabrication techniques, the present systems and methods can directly print nearly any size or shape medical device or instrument. For example, in certain embodiments, the present systems and methods leverage stereolithography (“SLA”) and photo-curable polymers to produce custom, radiopaque medical devices and instruments.